Press Releases

Minimum Deposit Casinos Reveals: Gen Z and Global Players Are Moving On From Credit Cards

WATERFORD, Ireland, July 31, 2025 (GLOBE NEWSWIRE) — Minimum Deposit Casinos (MDC), the global casino review platform operated by the OneTwenty Group, has published new findings showing that traditional credit cards are no longer the go-to for online casino players. The change is being led by Gen Z, who are choosing secure, wallet-based payment options […]

Press Releases

Namib Minerals Provides Corporate Update

NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) — Namib Minerals (“Namib Minerals” or “the Company”), (Nasdaq: NAMM), an established African gold producer with a portfolio of mining and exploration assets in Zimbabwe and the Democratic Republic of Congo, is pleased to provide a corporate update after closing the business combination with Hennessy Capital Investment Corp. […]

Press Releases

Axi Honoured with Five Awards by World Business Outlook Awards for 2025

SYDNEY, July 31, 2025 (GLOBE NEWSWIRE) — Axi, an industry-leading global broker, has been recognised with five awards* from the World Business Outlook Awards for 2025, marking a significant milestone in its continued growth and commitment to excellence: Best CFD Provider Australia Best Forex Trading Platform Australia Best 24/7 Customer Service Provider Australia Best Forex […]

Press Releases

DebitMyData Closes Oversubscribed Seed Round- Launches $1B Human Energy Grid Global Expansion

Seed raise exceeding 200% of target positions the DebitMyData Digital Identity LLM (DID-LLM) for Global Partnerships and Licensing DebitMyData Logo FORT LAUDERDALE, Fla., July 30, 2025 (GLOBE NEWSWIRE) — DebitMyData, Inc.—the powerhouse has closed a seed round at more than twice its original target. This surge of investor confidence paves the way for a bold, […]

Press Releases

Dr. Falk Pharma and Allianthera (Suzhou) Biopharmaceuticals Forge Strategic Partnership for Novel AhR Agonist Development

Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025: Dr. Falk Pharma GmbH and Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Announce Strategic Partnership to Develop a Novel AhR Agonist for the Treatment of Moderate to Severe Ulcerative Colitis  Dr. Falk Pharma GmbH, a research-based pharmaceutical company specializing in digestive and metabolic medicine, Allianthera (Suzhou) Biopharmaceuticals Co., […]